CN1277554A - 葡糖胺聚糖在生产用于治疗与糖尿病有关的眼疾病的药物制剂中的用途 - Google Patents

葡糖胺聚糖在生产用于治疗与糖尿病有关的眼疾病的药物制剂中的用途 Download PDF

Info

Publication number
CN1277554A
CN1277554A CN98810527A CN98810527A CN1277554A CN 1277554 A CN1277554 A CN 1277554A CN 98810527 A CN98810527 A CN 98810527A CN 98810527 A CN98810527 A CN 98810527A CN 1277554 A CN1277554 A CN 1277554A
Authority
CN
China
Prior art keywords
glycosaminoglycan
treatment
sulfate
diabetes
glycosaminoglycans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN98810527A
Other languages
English (en)
Chinese (zh)
Inventor
F·范德沃德
D·赫尔
V·劳克斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Knoll GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll GmbH filed Critical Knoll GmbH
Publication of CN1277554A publication Critical patent/CN1277554A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
CN98810527A 1997-10-24 1998-10-22 葡糖胺聚糖在生产用于治疗与糖尿病有关的眼疾病的药物制剂中的用途 Pending CN1277554A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19747195.1 1997-10-24
DE19747195A DE19747195A1 (de) 1997-10-24 1997-10-24 Verwendung von Glykosaminoglykanen zur Herstellung von pharmazeutischen Zubereitungen zur Behandlung von mit Diabetes assoziierten Augenkrankheiten

Publications (1)

Publication Number Publication Date
CN1277554A true CN1277554A (zh) 2000-12-20

Family

ID=7846613

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98810527A Pending CN1277554A (zh) 1997-10-24 1998-10-22 葡糖胺聚糖在生产用于治疗与糖尿病有关的眼疾病的药物制剂中的用途

Country Status (13)

Country Link
EP (1) EP1047434A2 (fr)
JP (1) JP2001520987A (fr)
KR (1) KR20010024550A (fr)
CN (1) CN1277554A (fr)
AU (1) AU749673B2 (fr)
BR (1) BR9813098A (fr)
CA (1) CA2306379A1 (fr)
DE (1) DE19747195A1 (fr)
HU (1) HUP0004647A3 (fr)
IL (1) IL135171A0 (fr)
NO (1) NO20001895L (fr)
WO (1) WO1999021538A2 (fr)
ZA (1) ZA989665B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101584704B (zh) * 2008-05-23 2010-12-15 鲁南制药集团股份有限公司 肝素、低分子肝素可药用盐或其衍生物的医药用途
CN107137421A (zh) * 2017-05-25 2017-09-08 青岛市中心医院 硫酸葡聚糖在制备抑制角膜血管新生药物中的应用

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI991503A1 (it) * 1999-07-08 2001-01-08 Bidifarm S R L Uso di metaboliti oligosaccaridici di proteoglicani come maker in fluidi biologici di diagnosi del biabete e delle complicanze patologiche c
WO2011122321A1 (fr) * 2010-03-29 2011-10-06 国立大学法人名古屋大学 Agent d'inhibition de l'activité physiologique de la protéine se liant à l'héparine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2597484B1 (fr) * 1986-04-17 1988-12-23 Sanofi Sa Glycosaminoglycanes de type heparine ou heparane-sulfate dotes d'une activite sur la division et la differentiation cellulaires, leur preparation et leurs applications therapeutiques.
JPH03500168A (ja) * 1988-06-27 1991-01-17 ライナー　ローラント 医薬の製造の為のグリコースアミノグリカンの使用
US5135920A (en) * 1988-11-16 1992-08-04 Takeda Chemical Industries, Ltd. Angiostatic agents
PT93847A (pt) * 1989-04-24 1990-11-20 Harvard College Processo para a preparacao de oligossacaridos de baixo peso molecular derivados de heparina ou de sulfato de heparano despolimerizados e de composicoes farmaceuticas que os contem
WO1995005182A1 (fr) * 1993-08-13 1995-02-23 Glycomed Incorporated Oligosaccharides pontes et leurs derives sulfates
EP0722326A4 (fr) * 1993-10-07 1999-10-06 Glycomed Inc Maltooligosaccharides fortement sulfatees presentant des proprietes semblables a l'heparine
US5643892A (en) * 1995-06-07 1997-07-01 Baker Norton Pharmaceuticals, Inc. Method of treating chronic progressive vascular diseases
WO1999004801A1 (fr) * 1997-07-28 1999-02-04 Rijks Universiteit Leiden Utilisation de glycosaminoglycanes sulfates dans le traitement de la retinopathie

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101584704B (zh) * 2008-05-23 2010-12-15 鲁南制药集团股份有限公司 肝素、低分子肝素可药用盐或其衍生物的医药用途
CN107137421A (zh) * 2017-05-25 2017-09-08 青岛市中心医院 硫酸葡聚糖在制备抑制角膜血管新生药物中的应用

Also Published As

Publication number Publication date
BR9813098A (pt) 2000-08-15
NO20001895D0 (no) 2000-04-12
KR20010024550A (ko) 2001-03-26
HUP0004647A3 (en) 2002-01-28
ZA989665B (en) 2000-04-25
WO1999021538A3 (fr) 1999-08-05
DE19747195A1 (de) 1999-04-29
IL135171A0 (en) 2001-05-20
JP2001520987A (ja) 2001-11-06
EP1047434A2 (fr) 2000-11-02
AU749673B2 (en) 2002-07-04
HUP0004647A2 (hu) 2001-05-28
WO1999021538A2 (fr) 1999-05-06
AU1335599A (en) 1999-05-17
NO20001895L (no) 2000-04-12
CA2306379A1 (fr) 1999-05-06

Similar Documents

Publication Publication Date Title
RU2519660C2 (ru) Режим дозировки селективного агониста рецептора s1p1
RU2201272C2 (ru) Применение ингибиторов желудочно-кишечной липазы
US20220202857A1 (en) Systems and methods for reducing low attenuation plaque and/or plaque burden in patients
EP2117549A1 (fr) Utilisation de la ranolazine dans le traitement des maladies microvasculaires coronaires
CN1373753A (zh) 氨氮地平和阿托伐他汀的公共盐
CN110420315A (zh) 枸杞糖肽在制备治疗三高药物中的应用
CN103328983A (zh) 决奈达隆在制备用于控制肝损伤风险的药物中的用途
JP2001089382A (ja) 早期血管再生及び低分子量ヘパリン投与による不安定冠動脈疾患の治療方法
AU749673B2 (en) Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye
US20230355561A1 (en) N-acetylcysteine attenuates aortic stenosis progression by inhibiting shear-mediated tgf-beta activation and fibrosis
CN101032512A (zh) 一种用于扩充血容量的药物组合物及其制备方法
WO2022150631A1 (fr) Systèmes et méthodes permettant de réduire la plaque à faible atténuation et/ou la charge de plaque chez des patients
EA018442B1 (ru) Применение l-карнитина для лечения гипертензии, для снижения систолического или пульсового давления крови у субъектов с предиабетом
CN1263093A (zh) 甲磺酸氨氯地平及其制法和应用
HK1033428A (en) Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye
CN1679924A (zh) 复方胰岛素能量合剂制剂及其应用
CN119564700B (zh) 帕珠沙星甲磺酸盐在制备治疗急性心肌梗死的药物的用途
Septian et al. 47. Non-atherosclerotic Myocardial Infarction (MI) as The Consequence of Hypertensive Emergencies (HE): what is the underlying possible mechanism?
RU2571067C2 (ru) Хронотерапевтическая фармацевтическая композиция
JP2875541B2 (ja) 血行再建術後の再閉塞防止剤
Sheeba et al. Renal Tubular Acidosis (RTA) due to Sjögren’s Syndrome Presenting as Hypokalemic Quadriparesis
Ogbomoh et al. Metformin-Associated Lactic Acidosis: A Case Report
CN113855799A (zh) 西达本胺联合利妥昔单抗在治疗老年复发难治性b细胞淋巴瘤疾病中的应用
Dixon Encephalopathy due to hyponatraemia in acute intermittent porphyria
CZ20001455A3 (cs) Použití glykosaminoglykanů pro přípravu farmaceutických přípravků pro léčení očních poruch spojených s diabetem

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1033428

Country of ref document: HK